Advanced Search
Article Contents
ABOUT THIS ARTICLE
The Innovation Oncology > 2026 Vol. 1 > No. 1 > 100005
Next Article Previous Article
COMMENTARY   Open Access     Cite

Beyond the “Prevention Paradox”: Prioritizing adherence-weighted effectiveness in China’s colorectal cancer screening strategy

  • 1.

    State Key Laboratory of Digestive Health, National Clinical Research Center for Digestive Diseases, General Surgery Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

More Information
  • Corresponding author: sur_yangyun@hotmail.com
  • Received Date:  January 20, 2026
    Accepted Date:  March 23, 2026
    Published Online:  March 31, 2026
The Innovation Oncology  1(1),  https://doi.org/10.59717/j.xinn-oncol.2026.100005  |  Cite this article
    • FullText(HTML)
  • 加载中
    • REFERENCES
  • [1] Dominitz J.A., Patel S.G. and Lieberman D.A. (2025). Blood-based colorectal cancer screening: The illusion of simplicity and the cancer prevention paradox. JAMA 334:29−31. DOI:10.1001/jama.2025.7557

    View in Article CrossRef Google Scholar

    [2] Shaukat A., Burke C.A., Chan A.T., et al. (2025). Clinical validation of a circulating tumor DNA-based blood test to screen for colorectal cancer. JAMA 334:56−63. DOI:10.1001/jama.2025.7515

    View in Article CrossRef Google Scholar

    [3] Zhu J., Jiang B., Zhu C., et al. (2026). Efficacy and cost-effectiveness of extending risk-stratified colorectal cancer screening: Evidence from China’s first province-wide program. Int. J. Surg. DOI:10.1097/JS9.0000000000004654

    View in Article Google Scholar

    [4] Hang D., Zhu C., Yang X., et al. (2025). Colorectal cancer screening based on fecal immunochemical test and risk assessment: A population-based study including two million participants in China. J. Epidemiol. 35:297−302. DOI:10.2188/jea.JE20240252

    View in Article CrossRef Google Scholar

    [5] Xie J., Dong X., Luo Z., et al. (2025). The impact of adherence on colorectal cancer screening cost-effectiveness: A modeling study. PLoS Med. 22:e1004807. DOI:10.1371/journal.pmed.1004807

    View in Article CrossRef Google Scholar

    • Cited by

  • Cite this article:

    Wang X., Wei L., Li Y., et al. (2026). Beyond the “Prevention Paradox”: Prioritizing adherence-weighted effectiveness in China’s colorectal cancer screening strategy. The Innovation Oncology 1:100005. https://doi.org/10.59717/j.xinn-oncol.2026.100005
    Wang X., Wei L., Li Y., et al. (2026). Beyond the “Prevention Paradox”: Prioritizing adherence-weighted effectiveness in China’s colorectal cancer screening strategy. The Innovation Oncology 1:100005. https://doi.org/10.59717/j.xinn-oncol.2026.100005

Welcome!

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.

PDF
Figures(1)    

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(939) PDF downloads(332)

Relative Articles

Cited by

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return

    {{newsColumn.name}}

    {{newsColumn.name}}

    Stay connected

    {{newsColumn.name}}

    Website copyright © Innovation Press. Published articles are licensed under CC BY with copyright retained by the authors.